CITADEL ADVISORS LLC - 09 Jul 2025 SCHEDULE 13G Report for Allogene Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares") (ALLO)

Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Kenneth Griffin
Security
Allogene Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares")
Symbol
ALLO
Shares outstanding
218,789,361 shares
Disclosed Ownership
13,346,151 shares
Ownership
6.1%
Form type
SCHEDULE 13G
Filing time
16 Jul 2025, 18:02:33 UTC
Date of event
09 Jul 2025
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 4.7% 10,203,329 0 10,203,329 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 4.7% 10,203,329 0 10,203,329 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 4.7% 10,203,329 0 10,203,329 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 1.4% 3,142,822 0 3,142,822 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities Group LP 1.4% 3,142,822 0 3,142,822 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities GP LLC 1.4% 3,142,822 0 3,142,822 /s/ Seth Levy Seth Levy, Authorized Signatory
Kenneth Griffin 6.1% 13,346,151 0 13,346,151 /s/ Seth Levy Seth Levy, attorney-in-fact*